25Serious

Nancy Sullivan

Ask VT AI

View News Summary

Trump's media company files for $2.3 billion stock sale, potentially diluting existing shares.
RH's Q4 revenue miss leads to stock drop, but the company remains focused on long-term growth and brand repositioning.
FDA delays Novavax COVID vaccine approval, raising concerns about regulatory efficiency after key resignation.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Trump's media company files for $2.3 billion stock sale, potentially diluting existing shares.
RH's Q4 revenue miss leads to stock drop, but the company remains focused on long-term growth and brand repositioning.
FDA delays Novavax COVID vaccine approval, raising concerns about regulatory efficiency after key resignation.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Nancy Sullivan